Post by
wildbird1 on Jul 11, 2021 10:24am
Exact number of tests...
Many people are asking about the exact number of tests "conducted" or "sold" in Q2 2021.
Conducted = Screenpro was involved.
Sold = Screenpro was not involved.
In the Discord July 5,2021 M.Gunter said " There are revenue question I can not address. Please don't send in the revenue questions, as I can't address those here".
Meaning;
Giving us the exact numbers and type of tests for Q2 2021 could give us the necessary tools to calculate Q2 revenues(it is a revenue question).
We might have to wait for Q2 financial(end of August 2021) to find out the tests revenues.
Telemidicine demand explode...
TSXU:DOC(CloudMD) a telemidicine company.
In the last year (the Covid-19 year)
DOC SP year low was $0.54.
DOC SP year high was $3.43.
An increase in SP value of 540%.
I am not trying to compare DOC to DM(DM AI&Telemidicine combined concept is different from DOC).
It is just to show that in the last year because of the Covid-19 the demand for Telemidicine has increased. People have developed an interest in Telemidicine that will continue to grow after the Covid-19 crisis is over.
The timing of Datametrex acquisition of a Telemidicine company is good, and Datametrex has over $13 million in the bank to push its AI&Telemidicine combined new concept.
With the demand for Telemidicine increasing Datametrex telemidicine acquisition could generate good profit faster than we think.
Comment by
swyint123888 on Jul 11, 2021 11:21am
60,000 pcr and 50,000 one drop in Q2 Q1 covid revs only were 18,600.000 and it had 90,000 pcr and 40,000 one drop Q 2 covid revs only = 18,600,000 so this 130,000 total of all tests works out to be 143 a pop I know it's crude but somewhat accurate so Q2 comes in at 16 mill or so under this crude and basic calculator